RBC Bioscience Corporation 6848.TWO Stock
RBC Bioscience Corporation Price Chart
RBC Bioscience Corporation 6848.TWO Financial and Trading Overview
| RBC Bioscience Corporation stock price | 15.5 TWD |
| Previous Close | 18.7 TWD |
| Open | 18.7 TWD |
| Bid | 16.8 TWD x N/A |
| Ask | 17.45 TWD x N/A |
| Day's Range | 16.9 - 18.7 TWD |
| 52 Week Range | 13.45 - 31.91 TWD |
| Volume | 85.72K TWD |
| Avg. Volume | 17.26K TWD |
| Market Cap | 220.59M TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 58.620693 |
| EPS (TTM) | -0.19 TWD |
| Forward Dividend & Yield | 1 (5.78%) |
| Ex-Dividend Date | July 21, 2022 |
| 1y Target Est | N/A |
6848.TWO Valuation Measures
| Enterprise Value | 644.57M TWD |
| Trailing P/E | 58.620693 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.2685647 |
| Price/Book (mrq) | 0.8865711 |
| Enterprise Value/Revenue | 3.707 |
| Enterprise Value/EBITDA | 25.745 |
Trading Information
RBC Bioscience Corporation Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -40.089% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 31.91 TWD |
| 52 Week Low | 13.45 TWD |
| 50-Day Moving Average | 17.43 TWD |
| 200-Day Moving Average | 18.78 TWD |
6848.TWO Share Statistics
| Avg. Volume (3 month) | 17.26K TWD |
| Avg. Daily Volume (10-Days) | 12.59K TWD |
| Shares Outstanding | 12.98M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.12 |
| Trailing Annual Dividend Yield | 5.98% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 3.4483 |
| Last Split Factor | 1100:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.17% |
| Operating Margin (ttm) | 4.45% |
| Gross Margin | 41.98% |
| EBITDA Margin | 14.39% |
Management Effectiveness
| Return on Assets (ttm) | 0.59% |
| Return on Equity (ttm) | 1.49% |
Income Statement
| Revenue (ttm) | 173.89M TWD |
| Revenue Per Share (ttm) | 13.4 TWD |
| Quarterly Revenue Growth (yoy) | -33.30% |
| Gross Profit (ttm) | 73.01M TWD |
| EBITDA | 25.04M TWD |
| Net Income Avi to Common (ttm) | 3.78M TWD |
| Diluted EPS (ttm) | 0.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 75.93M TWD |
| Total Cash Per Share (mrq) | 5.85 TWD |
| Total Debt (mrq) | 481.75M TWD |
| Total Debt/Equity (mrq) | 193.62 TWD |
| Current Ratio (mrq) | 1.268 |
| Book Value Per Share (mrq) | 19.175 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.6M TWD |
| Levered Free Cash Flow (ttm) | 19.92M TWD |
Profile of RBC Bioscience Corporation
| Country | Taiwan |
| State | N/A |
| City | New Taipei City |
| Address | No.132, Ln. 235, Baoqiao Road |
| ZIP | 23145 |
| Phone | 886 2 8912 1200 |
| Website | https://www.rbcbioscience.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
RBC Bioscience Corp. manufactures and sells reagents and devices for life science and molecular diagnosis in South Korea. It offers real genomics, such as accessories and equipment, DNA, DNA fragment, genomic DNA, plasmid, purification enzymes, RNA, and viral RNA; automated nucleic acid extractors; and nucleic acid extraction kits. The company sells its products through representatives and distributors. RBC Bioscience Corp. was founded in 2003 and is based in New Taipei City, Taiwan.
Q&A For RBC Bioscience Corporation Stock
What is a current 6848.TWO stock price?
RBC Bioscience Corporation 6848.TWO stock price today per share is 15.5 TWD.
How to purchase RBC Bioscience Corporation stock?
You can buy 6848.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RBC Bioscience Corporation?
The stock symbol or ticker of RBC Bioscience Corporation is 6848.TWO.
Which industry does the RBC Bioscience Corporation company belong to?
The RBC Bioscience Corporation industry is Biotechnology.
How many shares does RBC Bioscience Corporation have in circulation?
The max supply of RBC Bioscience Corporation shares is 12.98M.
What is RBC Bioscience Corporation Price to Earnings Ratio (PE Ratio)?
RBC Bioscience Corporation PE Ratio is now.
What was RBC Bioscience Corporation earnings per share over the trailing 12 months (TTM)?
RBC Bioscience Corporation EPS is -0.19 TWD over the trailing 12 months.
Which sector does the RBC Bioscience Corporation company belong to?
The RBC Bioscience Corporation sector is Healthcare.